Published May 28, 2019 | Version v1
Journal article Open

A COMPARATIVE RETROSPECTIVE STUDY ON FIV AND FeLV FROM JANUARY 1st 2013 TO DECEMBER 31st 2017

Authors/Creators

  • 1. Trakia University, Faculty of Veterinary Medicine, Stara Zagora, Bulgaria
  • 2. rakia University, Faculty of Veterinary Medicine, Stara Zagora, Bulgaria

Contributors

  • 1. University of Forestry, Bulgaria

Description

A comparative retrospective study of retrovirus infections among domestic cats was made in Small Animal Clinic of Faculty of Veterinary Medicine, Trakia University, Stara Zagora. Period from 1st January 2013 to December 31st 2017 is researched. As a diagnostic method was used SNAP® FIV/FeLV Combo Plus Test Kit, produced by IDEXX Laboratories Inc. Westbrook, Maine, USA. Exactly 130 blood sample tests were examined, 44 of which were positive and 96 were negative results. None of the tests were positive for together FIV ab and FeLV ag (p27).

Files

vol-4-2_2019-59-62.pdf

Files (125.2 kB)

Name Size
md5:3e7f165ac94ccf858802ae5a7d024c01
125.2 kB Preview Download

Additional details

Related works

Is documented by
http://scij-tmvm.com/vol./vol.4/2/vol-4-2_2019-59-62.pdf (URL)

References

  • Arjona A., Escolar E., Soto I. et al. (2000). Seroepidemiological survey of infection by feline leukemia virus and immunodeficiency virus in Madrid and correlation with some clinical aspects. J Clin Microbiol, Vol. 38(9): 3448–3449.
  • L. J. Gabor, D.N. Love, R. Malik, P. J. (2001). Canfield Feline immunodeficiency virus status of Australian cats with lymphosarcoma. Aust. Vet. J., Vol. 79(8);540–545.
  • Gleich S. E., Krieger S., Hartmann K. (2009). Prevalence of feline immunodeficiency virus and feline leukemia virus among client-owned cats and risk factors for infection in Germany. J. Fel. Med. Surg., Vol. 11: 985–989.
  • Hartmann K. (1998). Feline immunodeficiency virus infection: an overview. Vet. J. Vol. 155: 123– 137.
  • Hirsh, D., Y. Zee. (1999). Veterinary Microbiology. Blackwell Science, Inc.
  • Hosie M. J., Addie D., Belák S., et al. (2009). Feline immunodeficiency ABCD guidelines on prevention and management. J Feline Med Surg., Vol. 11: 575–584.
  • Ilia Tsachev. (2010). Infectious diseases in dogs and cats
  • T. Ishida, Y. Washizu, K. Toriyabe, S. Motoyoshi, I. Tomodo, N. C. (1989). Pedersen FIV infection in cats in Japan. J. Am. Vet. Med. Assoc., 194: 221–225.
  • Ishida T., Washizu T., Toriyabe K., Motoyoshi S., Tomoda I., Pedersen N. C. (1989). Feline immunodeficiency virus infection in cats of Japan. J. Am. Vet. Med. Assoc., Vol. 194: 221–225.
  • Julie K. Levy, Morgan Scott H., Jessica L. Lachtara, P. Crawford C. (2006). Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. Journal of the American Veterinary Medical Association, Vol. 228(3): 371–376.
  • L. S. Levy. (2008). Advances in understanding molecular determinants in FeLV pathology. Vet. Immunol. Immunopathol., Vol. 123(1–2): 14–22.
  • J.C. Neil, R. Fulton, M. Rigby, M. Stewart. (1991). Feline leukaemia virus: generation of pathogenic and oncogenic variants. Curr. Top. Microbiol. Immunol., Vol. 171: 67–93
  • T.Ç. Oğuzoğlu, Muz D., Timurkan M. Ö. et al. (2013). Prevalences of Feline Coronavirus (FCoV), Feline Leukaemia Virus (FeLV). Feline Immunodeficiency Virus (FIV) and Feline Parvovirus (FPV) among domestic cats in Ankara, Turkey. Revue Méd. Vét., Vol. 164(11): 511–516.
  • J. Overbaugh, C. R. Bangham. (2001). Selection forces and constraints on retroviral sequence variation. Science, Vol. 292(5519): 1106–1109
  • N. C. Pedersen, E. W. Ho, M. L. Brown, J. K. Yamamoto. (1987). Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency like syndrome. Science, Vol. 235: 790–793.
  • N. C. Pedersen, J. K. Yamamoto, T. Ishida, H. Hansen. (1989). Feline immunodeficiency virus infection. Vet Immunol. and Immunopathol., Vol. 21: 111–129.
  • N. C. Pedersen. Feline immunodeficiency virus, R. G. Webster, A. Granoff (Eds.). (1994). Encyclopaedia of virology. Academic Press, Philadelphia, PA, pp. 454–459.
  • L. J. Rezanka, J. L. Rojko, J. C. Neil. (1992). Feline leukemia virus: pathogenesis of neoplastic disease. Cancer Invest., Vol. 10(5): 371–389.
  • Susan Little, Bienzle D., Carioto L., Chisholm H, et all. (2011). Feline leukemia virus and feline immunodeficiency virus in Canada: Recommendations for testing and management. Can Vet J., Vol. 52: 849–855.
  • J. Stavisky, Dean RS., Molloy M. H. (2017). Prevalence of and risk factors for FIV and FeLV infection in two shelters in the United Kingdom (2011–2012). Vet Rec., Vol. 28, 181(17): 451.
  • E. Zenger. (1990). Clinical findings in cats with feline immunodeficiency virus. Feline Pract., Vol. 18: 25–28.